Literature DB >> 12832439

The critical role of ocular-infiltrating macrophages in the development of choroidal neovascularization.

Chikako Tsutsumi1, Koh-Hei Sonoda, Kensuke Egashira, Hong Qiao, Toshio Hisatomi, Shintaro Nakao, Minako Ishibashi, Israel F Charo, Taiji Sakamoto, Toshinori Murata, Tatsuro Ishibashi.   

Abstract

Choroidal neovascularization (CNV) is directly related to visual loss in some eye diseases, such as age-related macular degeneration. Although several human histological studies have suggested the participation of macrophages in CNV formation, the precise mechanisms are still not fully understood. In this study, we elucidated the role of ocular-infiltrating macrophages in experimental CNV using CCR2 knockout (KO) mice, wild-type mice, and C57BL/6 (B6) mice. CCR2 is the receptor of monocyte chemoattractant protein-1, and the number of infiltrating macrophage and the area of CNV were significantly reduced in CCR2 KO mice. Enriched ocular-infiltrating macrophages from B6 mice actually showed angiogenic ability in a dorsal air sac assay. Moreover, their expression of class II, CD40, B7-1 and B7-2 molecules, and the mRNA for potential angiogenic factors, such as vascular endothelial growth factor, basic fibroblast growth factor, and tumor necrosis factor alpha, was also observed. Collectively, we conclude that ocular-infiltrating macrophages play an important role in CNV generation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12832439     DOI: 10.1189/jlb.0902436

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  105 in total

Review 1.  Inflammation in diabetic retinopathy.

Authors:  Johnny Tang; Timothy S Kern
Journal:  Prog Retin Eye Res       Date:  2011-05-25       Impact factor: 21.198

Review 2.  Sphingosine-1-phosphate antibodies as potential agents in the treatment of cancer and age-related macular degeneration.

Authors:  Roger A Sabbadini
Journal:  Br J Pharmacol       Date:  2011-03       Impact factor: 8.739

Review 3.  Immunopathological aspects of age-related macular degeneration.

Authors:  Mrinali Patel; Chi-Chao Chan
Journal:  Semin Immunopathol       Date:  2008-02-26       Impact factor: 9.623

Review 4.  Immunological mechanisms in the pathogenesis of diabetic retinopathy.

Authors:  Anthony P Adamis; Adrienne J Berman
Journal:  Semin Immunopathol       Date:  2008-03-14       Impact factor: 9.623

Review 5.  Molecular pathology of age-related macular degeneration.

Authors:  Xiaoyan Ding; Mrinali Patel; Chi-Chao Chan
Journal:  Prog Retin Eye Res       Date:  2008-11-06       Impact factor: 21.198

6.  Genetic loci that control the size of laser-induced choroidal neovascularization.

Authors:  Kei Nakai; Michael S Rogers; Takashi Baba; Taisaku Funakoshi; Amy E Birsner; Dema S Luyindula; Robert J D'Amato
Journal:  FASEB J       Date:  2009-02-23       Impact factor: 5.191

Review 7.  Ocular neovascularization.

Authors:  Peter A Campochiaro
Journal:  J Mol Med (Berl)       Date:  2013-01-18       Impact factor: 4.599

8.  Angiogenic and Immunologic Proteins Identified by Deep Proteomic Profiling of Human Retinal and Choroidal Vascular Endothelial Cells: Potential Targets for New Biologic Drugs.

Authors:  Justine R Smith; Larry L David; Binoy Appukuttan; Phillip A Wilmarth
Journal:  Am J Ophthalmol       Date:  2018-03-17       Impact factor: 5.258

9.  Inhibition of development of laser-induced choroidal neovascularization with suppression of infiltration of macrophages in Smad3-null mice.

Authors:  Hiroki Iwanishi; Norihito Fujita; Katsuo Tomoyose; Yuka Okada; Osamu Yamanaka; Kathleen C Flanders; Shizuya Saika
Journal:  Lab Invest       Date:  2016-03-07       Impact factor: 5.662

10.  Lack of lymphatics and lymph node-mediated immunity in choroidal neovascularization.

Authors:  Shintaro Nakao; Souska Zandi; Ri-ichiro Kohno; Dawei Sun; Takahito Nakama; Keijiro Ishikawa; Shigeo Yoshida; Hiroshi Enaida; Tatsuro Ishibashi; Ali Hafezi-Moghadam
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-06-03       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.